Yasuko Rikihisa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yasuko Rikihisa has a total of 225 co-authors. Here are the top co-authors by number of shared publications:
- Mingqun Lin
Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210
35 shared publications Mingqun Lin
The College of Veterinary Medicine, Infectious Diseases Institute, The Ohio State University
15 shared publicationsNorio Ohashi
Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
14 shared publicationsQingming Xiong
Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA
13 shared publicationsZhihui Cheng
Department of Veterinary Biosciences, The Ohio State University, 1925 Coffey Road, Columbus, OH, 43210, USA
13 shared publicationsChunbin Zhang
Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
12 shared publications
Latest Publications
- Open Access
Recombinant Ehrlichia TRP75 Rescues Molting Failure of Ticks Infected with TRP75 Mutant Ehrlichia
Ehrlichia species are obligatory intracellular bacteria that exist in nature through a cycle of infection and transmission between ticks and their mammalian hosts, potentially causing a severe febrile illness called ehrlichiosis in humans and animals. Roles of Ehrlichia molecules in tick-mammal Ehrlichia transmission are mostly unknown. Tandem repeat protein (TRP) 75 is a lipoprotein conserved among Ehrlichia species. We identified and cloned a Himar1 transposon insertional mutant of Ehrlichia japonica that lacks C-terminal intrinsically disordered region of TRP75 (TRP75ΔC). This mutant was competent in infecting and replicating in both mammalian and tick cells in culture, and causing fatal illness similar to wild-type (WT) E. japonica . Upon feeding on TRP75ΔC and WT Ehrlichia -infected mice, both larval- and nymphal-stage of Ixodes scapularis ticks ingested similar amounts of blood meal as those fed on uninfected mice, and acquired similar levels of infection. However, most of TRP75ΔC Ehrlichia -infected ticks failed to complete molting, in contrast to successful molting of WT Ehrlichia -infected and uninfected ticks by 10 weeks post-feeding. In both WT Ehrlichia -infected and uninfected ticks, ∼1,000-fold exponential increase in ecdysone receptor (EcR) mRNA occurred at 15 days post-feeding, whereas EcR mRNA was not upregulated in TRP75ΔC Ehrlichia -infected ticks. Upon microinjection of recombinant full-length TRP75 protein into engorged ticks infected with TRP75ΔC Ehrlichia, molting efficiency was ∼90% restored, and there was significantly increased EcR mRNA compared with solvent microinjection control. This suggests that the endoparasitic bacterial molecule TRP75 manipulates the molting success of infected ticks and EcR mRNA levels for the survival of bacteria-hosted ticks and transstadial transmission. Importance: Tick-borne diseases represent an increasing threat throughout the world. Among these diseases are those caused by obligatory intracellular bacteria of the order Rickettsiales including members of Ehrlichia species. Effective prevention of tick-borne diseases requires an understanding of how disease-causing organisms thrive in ticks and are transmitted to mammals. Here, we used our mouse model of Ehrlichia japonica tick transmission to investigate the role of a single Ehrlichia factor, namely TRP75, using an isogenic Himar1 transposon mutant of TRP75 to infect mammalian and tick hosts and study transmission. Our results demonstrate that full-length TRP75 is necessary to permit molting of Ehrlichia- infected ticks via ecdysone receptor upregulation. The results provide new insights into the importance of bacterial factors in altering the molting and survival of infected ticks by allowing ecdysone signaling, thereby promoting pathogen survival and transmission.
Open AccessRecombinant Ehrlichia TRP75 Rescues Molting Failure of Ticks Infected with TRP75 Mutant Ehrlichia
Ehrlichia species are obligatory intracellular bacteria that exist in nature through a cycle of infection and transmission between ticks and their mammalian hosts, potentially causing a severe febrile illness called ehrlichiosis in humans and animals. Roles of Ehrlichia molecules in tick-mammal Ehrlichia transmission are mostly unknown. Tandem repeat protein (TRP) 75 is a lipoprotein conserved among Ehrlichia species. We identified and cloned a Himar1 transposon insertional mutant of Ehrlichia japonica that lacks C-terminal intrinsically disordered region of TRP75 (TRP75ΔC). This mutant was competent in infecting and replicating in both mammalian and tick cells in culture, and causing fatal illness similar to wild-type (WT) E. japonica . Upon feeding on TRP75ΔC and WT Ehrlichia -infected mice, both larval- and nymphal-stage of Ixodes scapularis ticks ingested similar amounts of blood meal as those fed on uninfected mice, and acquired similar levels of infection. However, most of TRP75ΔC Ehrlichia -infected ticks failed to complete molting, in contrast to successful molting of WT Ehrlichia -infected and uninfected ticks by 10 weeks post-feeding. In both WT Ehrlichia -infected and uninfected ticks, ∼1,000-fold exponential increase in ecdysone receptor (EcR) mRNA occurred at 15 days post-feeding, whereas EcR mRNA was not upregulated in TRP75ΔC Ehrlichia -infected ticks. Upon microinjection of recombinant full-length TRP75 protein into engorged ticks infected with TRP75ΔC Ehrlichia, molting efficiency was ∼90% restored, and there was significantly increased EcR mRNA compared with solvent microinjection control. This suggests that the endoparasitic bacterial molecule TRP75 manipulates the molting success of infected ticks and EcR mRNA levels for the survival of bacteria-hosted ticks and transstadial transmission. Importance: Tick-borne diseases represent an increasing threat throughout the world. Among these diseases are those caused by obligatory intracellular bacteria of the order Rickettsiales including members of Ehrlichia species. Effective prevention of tick-borne diseases requires an understanding of how disease-causing organisms thrive in ticks and are transmitted to mammals. Here, we used our mouse model of Ehrlichia japonica tick transmission to investigate the role of a single Ehrlichia factor, namely TRP75, using an isogenic Himar1 transposon mutant of TRP75 to infect mammalian and tick hosts and study transmission. Our results demonstrate that full-length TRP75 is necessary to permit molting of Ehrlichia- infected ticks via ecdysone receptor upregulation. The results provide new insights into the importance of bacterial factors in altering the molting and survival of infected ticks by allowing ecdysone signaling, thereby promoting pathogen survival and transmission.
- Open Access
- 8 July 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (7) , e0113426
Anaplasma phagocytophilum subversion of host hepcidin-ferroportin iron nutritional immunity
Obligatory intracellular bacterium Anaplasma phagocytophilum ( Aph ) causes an emerging infectious disease called human granulocytic anaplasmosis. Within host cells, Aph proliferates in a membrane-bound vacuole ( Aph -vacuole) to which all required nutrients must be routed, including essential iron. Here, using a fluorescent labile iron-binding dye in live image analysis, we found that Aph -vacuoles are enriched with labile iron. Furthermore, ferroportin (Fpn), the only known iron exporter on the plasma membrane of host cells, increasingly encircled the Aph -vacuole post-invasion in a ring-like pattern. Fpn is regulated by the hormone hepcidin, which binds to Fpn and triggers its ubiquitination and internalization, thereby, inhibits iron availability to blood-borne pathogens. Fpn-GFP mutants deficient in ubiquitination (domain deletion or Y64H) did not encircle Aph- vacuoles. Fpn-GFP (D181V) and Fpn-GFP (D39A) mutants that are deficient in iron binding and transport could encircle Aph- vacuoles, but unlike Fpn-GFP (wild-type) did not increase labile iron in Aph -vacuoles or Aph growth. The gene encoding hepcidin is upregulated by inflammation. We found Aph infection induced the expression of the hepcidin mRNA and protein, and strong IL-6, IL-1β, and TNF-α mRNA expression by host cells. Altogether, these results suggest that Aph induces the production of proinflammatory cytokines for the upregulation of hepcidin which triggers the Fpn endocytosis and encasement of Aph- vacuoles in a ubiquitination-dependent manner. Fpn internalization raises host cell cytoplasmic iron and may export iron into the vacuoles to enrich intravacuolar iron for the benefit of bacteria. This finding demonstrates pathogen manipulation of cellular iron export mechanisms and subversion of host hepcidin-Fpn iron nutritional immunity against pathogens. IMPORTANCE: Iron is an essential element for both humans and microorganisms, serving as a cofactor in key metabolic processes. Obligatory intracellular bacterium Anaplasma phagocytophilum infects and proliferates within a membrane-bound vacuole ( Aph- vacuoles) of neutrophils and endothelial cells, competitively acquiring intracellular iron from the host. Upon exploration of cytoplasmic labile free iron levels and distribution in the A. phagocytophilum -infected and uninfected host cells, we uncovered the unique ability of this bacterium to enrich intravacuolar iron. Ferroportin is the only cellular iron exporter of host cells, which is regulated by the hepatic hormone hepcidin. Herein, we investigate the role of ferroportin and endogenous hepcidin locally produced by infected host cells for iron enrichment in Aph- vacuoles. Ultimately, this study provides new insights into the novel mechanisms of microbial manipulation of host cells to acquire the essential micronutrient iron and overcoming host nutritional immunity, which may facilitate more effective treatment and prevention.
- 8 July 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (7) , e0113426
Open AccessAnaplasma phagocytophilum subversion of host hepcidin-ferroportin iron nutritional immunity
Obligatory intracellular bacterium Anaplasma phagocytophilum ( Aph ) causes an emerging infectious disease called human granulocytic anaplasmosis. Within host cells, Aph proliferates in a membrane-bound vacuole ( Aph -vacuole) to which all required nutrients must be routed, including essential iron. Here, using a fluorescent labile iron-binding dye in live image analysis, we found that Aph -vacuoles are enriched with labile iron. Furthermore, ferroportin (Fpn), the only known iron exporter on the plasma membrane of host cells, increasingly encircled the Aph -vacuole post-invasion in a ring-like pattern. Fpn is regulated by the hormone hepcidin, which binds to Fpn and triggers its ubiquitination and internalization, thereby, inhibits iron availability to blood-borne pathogens. Fpn-GFP mutants deficient in ubiquitination (domain deletion or Y64H) did not encircle Aph- vacuoles. Fpn-GFP (D181V) and Fpn-GFP (D39A) mutants that are deficient in iron binding and transport could encircle Aph- vacuoles, but unlike Fpn-GFP (wild-type) did not increase labile iron in Aph -vacuoles or Aph growth. The gene encoding hepcidin is upregulated by inflammation. We found Aph infection induced the expression of the hepcidin mRNA and protein, and strong IL-6, IL-1β, and TNF-α mRNA expression by host cells. Altogether, these results suggest that Aph induces the production of proinflammatory cytokines for the upregulation of hepcidin which triggers the Fpn endocytosis and encasement of Aph- vacuoles in a ubiquitination-dependent manner. Fpn internalization raises host cell cytoplasmic iron and may export iron into the vacuoles to enrich intravacuolar iron for the benefit of bacteria. This finding demonstrates pathogen manipulation of cellular iron export mechanisms and subversion of host hepcidin-Fpn iron nutritional immunity against pathogens. IMPORTANCE: Iron is an essential element for both humans and microorganisms, serving as a cofactor in key metabolic processes. Obligatory intracellular bacterium Anaplasma phagocytophilum infects and proliferates within a membrane-bound vacuole ( Aph- vacuoles) of neutrophils and endothelial cells, competitively acquiring intracellular iron from the host. Upon exploration of cytoplasmic labile free iron levels and distribution in the A. phagocytophilum -infected and uninfected host cells, we uncovered the unique ability of this bacterium to enrich intravacuolar iron. Ferroportin is the only cellular iron exporter of host cells, which is regulated by the hepatic hormone hepcidin. Herein, we investigate the role of ferroportin and endogenous hepcidin locally produced by infected host cells for iron enrichment in Aph- vacuoles. Ultimately, this study provides new insights into the novel mechanisms of microbial manipulation of host cells to acquire the essential micronutrient iron and overcoming host nutritional immunity, which may facilitate more effective treatment and prevention.
- Open Access
- 24 June 2026
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (6) , e1014350
Obligatory intracellular bacterium Anaplasma phagocytophilum AnkA regulates actin dynamics and spatiotemporal bacterial release
Anaplasma phagocytophilum is an obligatory intracellular bacterium that causes an emerging infectious disease, human granulocytic anaplasmosis. It undergoes a biphasic developmental cycle inside membrane-bound vacuoles within the host human neutrophils, maturing from a proliferating reticulate cell form to an infectious dense core (DC) form that is subsequently spontaneously released from host cells to initiate a new infection cycle. However, how A. phagocytophilum coordinates growth and release is unknown. Here, we found localized cortical F-actin disruption occurs where Anaplasma- containing vacuoles abut on the plasma membrane to release bacteria. Disruption of actin filaments by cytochalasin D and latrunculin B induced unrestrained release of almost all intracellular A. phagocytophilum from host cells, which were significantly less infectious than spontaneously released bacteria. A. phagocytophilum AnkA, a type IV secretion system (T4SS) effector, was found to localize in the cell periphery with cortical F-actin. By immunoprecipitation followed by mass spectrometry, AnkA was found to interact with actin, α-actinin 4 (Actn4) involved in actin cross-linking, and gelsolin for actin filament remodeling. shRNA-knockdown of Actn4 or gelsolin, enhanced release of premature A. phagocytophilum . Glutathione S-transferase (GST)-tagged C-terminus of AnkA (AnkA-C) interacted with actin and gelsolin, whereas the N-terminus (AnkA-N) interacted with Actn4. In vitro pyrene-actin polymerization assay showed that GST-AnkA-C has stronger actin polymerizing activity than GST-AnkA or GST-AnkA-N. Ectopically expressed GFP-AnkA-N localized to the plasma membrane and induced membrane ruffling, whereas GFP-AnkA-C colocalized with and enhanced stress fiber formation. These results demonstrate that AnkA is the first example of bacterial molecules interacting with gelsolin and Actn4. The result suggests that by colocalizing with cortical F-actin and controlling F-actin dynamics and cross-linking, AnkA regulates spatiotemporal release of A. phagocytophilum . The current study unravels a new paradigm of retention/release mechanism of intracellular pathogen regulated by a T4SS effector.
- 24 June 2026
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (6) , e1014350
Open AccessObligatory intracellular bacterium Anaplasma phagocytophilum AnkA regulates actin dynamics and spatiotemporal bacterial release
Anaplasma phagocytophilum is an obligatory intracellular bacterium that causes an emerging infectious disease, human granulocytic anaplasmosis. It undergoes a biphasic developmental cycle inside membrane-bound vacuoles within the host human neutrophils, maturing from a proliferating reticulate cell form to an infectious dense core (DC) form that is subsequently spontaneously released from host cells to initiate a new infection cycle. However, how A. phagocytophilum coordinates growth and release is unknown. Here, we found localized cortical F-actin disruption occurs where Anaplasma- containing vacuoles abut on the plasma membrane to release bacteria. Disruption of actin filaments by cytochalasin D and latrunculin B induced unrestrained release of almost all intracellular A. phagocytophilum from host cells, which were significantly less infectious than spontaneously released bacteria. A. phagocytophilum AnkA, a type IV secretion system (T4SS) effector, was found to localize in the cell periphery with cortical F-actin. By immunoprecipitation followed by mass spectrometry, AnkA was found to interact with actin, α-actinin 4 (Actn4) involved in actin cross-linking, and gelsolin for actin filament remodeling. shRNA-knockdown of Actn4 or gelsolin, enhanced release of premature A. phagocytophilum . Glutathione S-transferase (GST)-tagged C-terminus of AnkA (AnkA-C) interacted with actin and gelsolin, whereas the N-terminus (AnkA-N) interacted with Actn4. In vitro pyrene-actin polymerization assay showed that GST-AnkA-C has stronger actin polymerizing activity than GST-AnkA or GST-AnkA-N. Ectopically expressed GFP-AnkA-N localized to the plasma membrane and induced membrane ruffling, whereas GFP-AnkA-C colocalized with and enhanced stress fiber formation. These results demonstrate that AnkA is the first example of bacterial molecules interacting with gelsolin and Actn4. The result suggests that by colocalizing with cortical F-actin and controlling F-actin dynamics and cross-linking, AnkA regulates spatiotemporal release of A. phagocytophilum . The current study unravels a new paradigm of retention/release mechanism of intracellular pathogen regulated by a T4SS effector.
- Open Access
- 30 March 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1) , 2645860
Efficacy and immunological correlates of an mRNA-LNP vaccine for protection against an emerging rickettsial pathogen
A rickettsial pathogen Ehrlichia chaffeensis causes emerging tick-borne disease called human monocytic ehrlichiosis (HME). E. chaffeensis in ticks expresses a porin OMP-1B, the immunodominant major outer membrane protein, which is required for nutrient uptake across outer membrane of bacteria. We developed an OMP-1B-encoding mRNA-lipid nanoparticle (hereafter OMP-1B mRNA-LNP) vaccine. Immunization of naïve mice with OMP-1B mRNA-LNP showed significant protection against E. chaffeensis infection following challenge with E. chaffeensis-infected tick cells. Following vaccination, increased OMP-1B-specific serum IgG, IgG1, and IgG2a titers, and E. chaffeensis infection-neutralizing antibodies were detected. An ELISpot assay revealed significant increase in OMP-1B-specific IFN-γ-secreting cells in the blood and spleen samples from mice vaccinated with OMP-1B mRNA-LNP. Flow cytometry analysis of spleen samples showed OMP-1B antigen-specific IFN-γ-producing CD4+ and CD8+ T cells and granzyme B-producing cytotoxic CD8+ T cells were significantly increased in the vaccinated mice. Our results demonstrate that an mRNA vaccine targeting OMP-1B conferred protection against E. chaffeensis infection, with significant humoral immune responses including infection-neutralizing antibodies, balanced Th1/Th2 response, and antigen-specific T helper and cytotoxic T cell activation. These data suggest mRNA-LNP approach is a viable strategy for developing efficient anti-rickettsial vaccines.
- 30 March 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1) , 2645860
Open AccessEfficacy and immunological correlates of an mRNA-LNP vaccine for protection against an emerging rickettsial pathogen
A rickettsial pathogen Ehrlichia chaffeensis causes emerging tick-borne disease called human monocytic ehrlichiosis (HME). E. chaffeensis in ticks expresses a porin OMP-1B, the immunodominant major outer membrane protein, which is required for nutrient uptake across outer membrane of bacteria. We developed an OMP-1B-encoding mRNA-lipid nanoparticle (hereafter OMP-1B mRNA-LNP) vaccine. Immunization of naïve mice with OMP-1B mRNA-LNP showed significant protection against E. chaffeensis infection following challenge with E. chaffeensis-infected tick cells. Following vaccination, increased OMP-1B-specific serum IgG, IgG1, and IgG2a titers, and E. chaffeensis infection-neutralizing antibodies were detected. An ELISpot assay revealed significant increase in OMP-1B-specific IFN-γ-secreting cells in the blood and spleen samples from mice vaccinated with OMP-1B mRNA-LNP. Flow cytometry analysis of spleen samples showed OMP-1B antigen-specific IFN-γ-producing CD4+ and CD8+ T cells and granzyme B-producing cytotoxic CD8+ T cells were significantly increased in the vaccinated mice. Our results demonstrate that an mRNA vaccine targeting OMP-1B conferred protection against E. chaffeensis infection, with significant humoral immune responses including infection-neutralizing antibodies, balanced Th1/Th2 response, and antigen-specific T helper and cytotoxic T cell activation. These data suggest mRNA-LNP approach is a viable strategy for developing efficient anti-rickettsial vaccines.
- Open Access
- 6 March 2026
- Published by Elsevier in Veterinary Microbiology
- Vol. 316, 110963
Equine neorickettsiosis: A global perspective of the natural habitat of the bacteria and clinical disease
- 6 March 2026
- Published by Elsevier in Veterinary Microbiology
- Vol. 316, 110963
Open AccessEquine neorickettsiosis: A global perspective of the natural habitat of the bacteria and clinical disease
- Open Access
Anaplasma phagocytophilum Subversion of Host Hepcidin-Ferroportin Iron Nutritional Immunity
Obligatory intracellular bacterium Anaplasma phagocytophilum ( Aph ) causes an emerging infectious disease called human granulocytic anaplasmosis. Within host cells, Aph proliferates in a membrane-bound vacuole ( Aph -vacuole), to which all required nutrients must be routed, including essential iron. Here, using a fluorescent labile iron-binding dye, we found that Aph -vacuoles are enriched with labile iron. Further, ferroportin (Fpn), the only known iron exporter in the plasma membrane of host cells, was increasingly localized to Aph -vacuole post-invasion. Plasma membrane Fpn is tightly regulated by the hormone hepcidin, which binds to Fpn and triggers its ubiquitination and internalization. We found Fpn-GFP mutants deficient in ubiquitination (domain deletion or Y64H) had reduced or absent localization to Aph- vacuoles. Fpn-GFP (D131V) and Fpn-GFP (D039A) mutants that are deficient in iron binding and transport could still localize to Aph- vacuoles, but significantly reduced Aph growth and labile iron in Aph -vacuoles. Aph infection upregulated host cell expression of the hepcidin mRNA and protein. Furthermore, the gene encoding hepcidin is upregulated by inflammation, and we found Aph induced strong IL-6, IL-1β, and TNF-α mRNA expression in the host cells. Altogether, these results suggest that Aph induces production of proinflammatory cytokines for autocrine or paracrine hepcidin secretion to trigger the Fpn internalization, which can then be diverted to Aph -vacuoles in a ubiquitination-dependent manner as a mechanism of iron acquisition for thebacteria. This finding illuminates pathogen manipulation of cellular iron export mechanisms, and subversion of host hepcidin-Fpn iron nutritional immunity against pathogens. IMPORTANCE: Iron is an essential element for both humans and microorganisms, serving as a cofactor in key metabolic processes. Obligatory intracellular bacterium Anaplasma phagocytophilum infects and proliferates within a membrane-bound vacuole ( Aph- vacuoles) of neutrophils and endothelial cells, competitively acquiring intracellular iron from the host. Upon exploration of cytoplasmic labile free iron levels and distribution in the A. phagocytophilum -infected and uninfected host cells, we uncovered the unique ability of this bacterium to enrich intravacuolar iron. Ferroportin is the only cellular iron exporter of the host cells, which is regulated by the hepatic hormone hepcidin. Herein, we investigate the role of ferroportin and endogenous hepcidin locally produced by the host cells for iron enrichment in Aph- vacuoles. Ultimately, this study provides new insights into the novel mechanisms of microbial manipulation of host cells to acquire the essential micronutrient iron and overcoming host nutritional immunity, which may facilitate more effective treatment and prevention.
Open AccessAnaplasma phagocytophilum Subversion of Host Hepcidin-Ferroportin Iron Nutritional Immunity
Obligatory intracellular bacterium Anaplasma phagocytophilum ( Aph ) causes an emerging infectious disease called human granulocytic anaplasmosis. Within host cells, Aph proliferates in a membrane-bound vacuole ( Aph -vacuole), to which all required nutrients must be routed, including essential iron. Here, using a fluorescent labile iron-binding dye, we found that Aph -vacuoles are enriched with labile iron. Further, ferroportin (Fpn), the only known iron exporter in the plasma membrane of host cells, was increasingly localized to Aph -vacuole post-invasion. Plasma membrane Fpn is tightly regulated by the hormone hepcidin, which binds to Fpn and triggers its ubiquitination and internalization. We found Fpn-GFP mutants deficient in ubiquitination (domain deletion or Y64H) had reduced or absent localization to Aph- vacuoles. Fpn-GFP (D131V) and Fpn-GFP (D039A) mutants that are deficient in iron binding and transport could still localize to Aph- vacuoles, but significantly reduced Aph growth and labile iron in Aph -vacuoles. Aph infection upregulated host cell expression of the hepcidin mRNA and protein. Furthermore, the gene encoding hepcidin is upregulated by inflammation, and we found Aph induced strong IL-6, IL-1β, and TNF-α mRNA expression in the host cells. Altogether, these results suggest that Aph induces production of proinflammatory cytokines for autocrine or paracrine hepcidin secretion to trigger the Fpn internalization, which can then be diverted to Aph -vacuoles in a ubiquitination-dependent manner as a mechanism of iron acquisition for thebacteria. This finding illuminates pathogen manipulation of cellular iron export mechanisms, and subversion of host hepcidin-Fpn iron nutritional immunity against pathogens. IMPORTANCE: Iron is an essential element for both humans and microorganisms, serving as a cofactor in key metabolic processes. Obligatory intracellular bacterium Anaplasma phagocytophilum infects and proliferates within a membrane-bound vacuole ( Aph- vacuoles) of neutrophils and endothelial cells, competitively acquiring intracellular iron from the host. Upon exploration of cytoplasmic labile free iron levels and distribution in the A. phagocytophilum -infected and uninfected host cells, we uncovered the unique ability of this bacterium to enrich intravacuolar iron. Ferroportin is the only cellular iron exporter of the host cells, which is regulated by the hepatic hormone hepcidin. Herein, we investigate the role of ferroportin and endogenous hepcidin locally produced by the host cells for iron enrichment in Aph- vacuoles. Ultimately, this study provides new insights into the novel mechanisms of microbial manipulation of host cells to acquire the essential micronutrient iron and overcoming host nutritional immunity, which may facilitate more effective treatment and prevention.
- Open Access
- 12 August 2025
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 32 (1) , 1-15
Development of mRNA–lipid nanoparticle intrabodies against rickettsial infection
Background: Rickettsiosis is among the deadliest vector-borne infectious diseases worldwide, in part because rickettsiae replicate within human cells, where antibodies and most drugs cannot effectively reach this obligatory intracellular pathogen. Ehrlichia chaffeensis, an emerging rickettsia, is the causative agent of human monocytic ehrlichiosis. We therefore aim to generate intrabodies (IBs), the variable domain of heavy chain of heavy-chain-only antibodies (VHHs) that bind intracellular bacterial proteins to inhibit E. chaffeensis infection. Methods: E. chaffeensis replicates in membrane-bound vacuoles resembling early endosomes in human monocytes/macrophages. The type IV secretion system effector Ehrlichia translocated factor-2 (Etf-2) directly binds to RAB5-GTP on E. chaffeensis-containing vacuoles. Consequently, Etf-2 hinders the engagement of RAB5 GTPase-activating protein with RAB5-GTP, delays maturation of Ehrlichia vacuoles to late endosomes, thus facilitates infection. As C-terminal half of Etf-2 (Etf-2C) binds RAB5-GTP, a random synthetic library of VHHs was screened for binding to Etf-2C, and for inhibition of Etf-2 binding to RAB5 in human cells when expressed intracellularly (IBs). Positive IBs were tested for inhibition of Etf-2 functions and E. chaffeensis infection, and lipid nanoparticles-encapsulated mRNAs (mRNAs-LNP) platform was used to deliver IBs in vitro and in mice. Results: We have identified two distinct IBs that inhibit Etf-2 binding to RAB5 and Etf-2 functions in vitro. Synthesized mRNA-LNP encoding anti-Etf-2 IBs significantly inhibited E. chaffeensis infection in cell cultures and in a mouse model. Conclusions: The results demonstrate the feasibility of mRNA-LNP encoding IBs as intracellular probes and a precision therapy addressing underlying cause of obligatory intracellular infection.
- 12 August 2025
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 32 (1) , 1-15
Open AccessDevelopment of mRNA–lipid nanoparticle intrabodies against rickettsial infection
Background: Rickettsiosis is among the deadliest vector-borne infectious diseases worldwide, in part because rickettsiae replicate within human cells, where antibodies and most drugs cannot effectively reach this obligatory intracellular pathogen. Ehrlichia chaffeensis, an emerging rickettsia, is the causative agent of human monocytic ehrlichiosis. We therefore aim to generate intrabodies (IBs), the variable domain of heavy chain of heavy-chain-only antibodies (VHHs) that bind intracellular bacterial proteins to inhibit E. chaffeensis infection. Methods: E. chaffeensis replicates in membrane-bound vacuoles resembling early endosomes in human monocytes/macrophages. The type IV secretion system effector Ehrlichia translocated factor-2 (Etf-2) directly binds to RAB5-GTP on E. chaffeensis-containing vacuoles. Consequently, Etf-2 hinders the engagement of RAB5 GTPase-activating protein with RAB5-GTP, delays maturation of Ehrlichia vacuoles to late endosomes, thus facilitates infection. As C-terminal half of Etf-2 (Etf-2C) binds RAB5-GTP, a random synthetic library of VHHs was screened for binding to Etf-2C, and for inhibition of Etf-2 binding to RAB5 in human cells when expressed intracellularly (IBs). Positive IBs were tested for inhibition of Etf-2 functions and E. chaffeensis infection, and lipid nanoparticles-encapsulated mRNAs (mRNAs-LNP) platform was used to deliver IBs in vitro and in mice. Results: We have identified two distinct IBs that inhibit Etf-2 binding to RAB5 and Etf-2 functions in vitro. Synthesized mRNA-LNP encoding anti-Etf-2 IBs significantly inhibited E. chaffeensis infection in cell cultures and in a mouse model. Conclusions: The results demonstrate the feasibility of mRNA-LNP encoding IBs as intracellular probes and a precision therapy addressing underlying cause of obligatory intracellular infection.
- 16 December 2024
- Published by Elsevier in Microbiological Research
- Vol. 292, 128027
Development of Etf-3-specific nanobodies to prevent Ehrlichia infection and LNP-mRNA delivery in cellular and murine models
- 16 December 2024
- Published by Elsevier in Microbiological Research
- Vol. 292, 128027
Development of Etf-3-specific nanobodies to prevent Ehrlichia infection and LNP-mRNA delivery in cellular and murine models
- Open Access
- 1 October 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1416577
RipE expression correlates with high ATP levels in Ehrlichia, which confers resistance during the extracellular stage to facilitate a new cycle of infection
Ehrlichiosis is a potentially life-threatening disease caused by infection with the obligatory intracellular bacteria Ehrlichia species. Ehrlichia japonica infection of mice provides an animal model of ehrlichiosis as it recapitulates full-spectrum and lethal ehrlichiosis in humans. The E. japonica transposon mutant of EHF0962, which encodes a previously uncharacterized hypothetical protein, is attenuated in both infection and virulence in mice. EHF0962 was hence named here as resistance-inducing protein of Ehrlichia (RipE). Using this ΔripE mutant, we studied how RipE protein contributes to Ehrlichia pathogenesis. Ehrlichia species have an intracellular developmental cycle and a brief extracellular stage to initiate a new cycle of infection. Majority of RipE proteins were expressed on the surface of the smaller infectious dense-core stage of bacteria. Extracellular ΔripE E. japonica contained significantly less adenosine triphosphate (ATP) and lost infectivity more rapidly in culture compared with wild-type (WT) E. japonica. Genetic complementation in the ΔripE mutant or overexpression of ripE in WT E. japonica significantly increased bacterial ATP levels, and RipE-overexpressing E. japonica was more virulent in mice than WT E. japonica. RipE is conserved among Ehrlichia species. Immunization of mice with recombinant RipE induced an in vitro infection-neutralizing antibody, significantly prolonged survival time after a lethal dose of E. japonica challenge, and cross-protected mice from infection by Ehrlichia chaffeensis, the agent of human monocytic ehrlichiosis. Our findings shed light on the extracellular stage of Ehrlichia, highlighting the importance of RipE and ATP levels in Ehrlichia for extracellular resistance and the next cycle of infection. Thus, RipE is a critical Ehrlichia protein for infection as such can be a potential vaccine target for ehrlichiosis.
- 1 October 2024
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1416577
Open AccessRipE expression correlates with high ATP levels in Ehrlichia, which confers resistance during the extracellular stage to facilitate a new cycle of infection
Ehrlichiosis is a potentially life-threatening disease caused by infection with the obligatory intracellular bacteria Ehrlichia species. Ehrlichia japonica infection of mice provides an animal model of ehrlichiosis as it recapitulates full-spectrum and lethal ehrlichiosis in humans. The E. japonica transposon mutant of EHF0962, which encodes a previously uncharacterized hypothetical protein, is attenuated in both infection and virulence in mice. EHF0962 was hence named here as resistance-inducing protein of Ehrlichia (RipE). Using this ΔripE mutant, we studied how RipE protein contributes to Ehrlichia pathogenesis. Ehrlichia species have an intracellular developmental cycle and a brief extracellular stage to initiate a new cycle of infection. Majority of RipE proteins were expressed on the surface of the smaller infectious dense-core stage of bacteria. Extracellular ΔripE E. japonica contained significantly less adenosine triphosphate (ATP) and lost infectivity more rapidly in culture compared with wild-type (WT) E. japonica. Genetic complementation in the ΔripE mutant or overexpression of ripE in WT E. japonica significantly increased bacterial ATP levels, and RipE-overexpressing E. japonica was more virulent in mice than WT E. japonica. RipE is conserved among Ehrlichia species. Immunization of mice with recombinant RipE induced an in vitro infection-neutralizing antibody, significantly prolonged survival time after a lethal dose of E. japonica challenge, and cross-protected mice from infection by Ehrlichia chaffeensis, the agent of human monocytic ehrlichiosis. Our findings shed light on the extracellular stage of Ehrlichia, highlighting the importance of RipE and ATP levels in Ehrlichia for extracellular resistance and the next cycle of infection. Thus, RipE is a critical Ehrlichia protein for infection as such can be a potential vaccine target for ehrlichiosis.
- Open Access
- 6 August 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (33)
Anaplasma phagocytophilum effector EgeA facilitates infection by hijacking TANGO1 and SCFD1 from ER–Golgi exit sites to pathogen-occupied inclusions
The obligatory intracellular bacterium Anaplasma phagocytophilum causes human granulocytic anaplasmosis, an emerging zoonosis. Anaplasma has limited biosynthetic and metabolic capacities, yet it effectively replicates inside of inclusions/vacuoles of eukaryotic host cells. Here, we describe a unique Type IV secretion system (T4SS) effector, E R– G olgi e xit site protein of A naplasma (EgeA). In cells infected by Anaplasma , secreted native EgeA, EgeA-GFP, and the C-terminal half of EgeA (EgeA-C)-GFP localized to Anaplasma- containing inclusions. In uninfected cells, EgeA-C-GFP localized to cis-Golgi, whereas the N-terminal half of EgeA-GFP localized to the ER. Pull-down assays identified EgeA-GFP binding to a transmembrane protein in the ER, Transport and Golgi organization protein 1 (TANGO1). By yeast two-hybrid analysis, EgeA-C directly bound Sec1 family domain-containing protein 1 (SCFD1), a host protein of the cis-Golgi network that binds TANGO1 at ER–Golgi exit sites (ERES). Both TANGO1 and SCFD1 localized to the Anaplasma inclusion surface. Furthermore, knockdown of Anaplasma EgeA or either host TANGO1 or SCFD1 significantly reduced Anaplasma infection. TANGO1 and SCFD1 prevent ER congestion and stress by facilitating transport of bulky or unfolded proteins at ERES. A bulky cargo collagen and the ER-resident chaperon BiP were transported into Anaplasma inclusions, and several ER stress marker genes were not up-regulated in Anaplasma- infected cells. Furthermore, EgeA transfection reduced collagen overexpression-induced BiP upregulation. These results suggest that by binding to the two ERES proteins, EgeA redirects the cargo-adapted ERES to pathogen-occupied inclusions and reduces ERES congestion, which facilitates Anaplasma nutrient acquisition and reduces ER stress for Anaplasma survival and proliferation.
- 6 August 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (33)
Open AccessAnaplasma phagocytophilum effector EgeA facilitates infection by hijacking TANGO1 and SCFD1 from ER–Golgi exit sites to pathogen-occupied inclusions
The obligatory intracellular bacterium Anaplasma phagocytophilum causes human granulocytic anaplasmosis, an emerging zoonosis. Anaplasma has limited biosynthetic and metabolic capacities, yet it effectively replicates inside of inclusions/vacuoles of eukaryotic host cells. Here, we describe a unique Type IV secretion system (T4SS) effector, E R– G olgi e xit site protein of A naplasma (EgeA). In cells infected by Anaplasma , secreted native EgeA, EgeA-GFP, and the C-terminal half of EgeA (EgeA-C)-GFP localized to Anaplasma- containing inclusions. In uninfected cells, EgeA-C-GFP localized to cis-Golgi, whereas the N-terminal half of EgeA-GFP localized to the ER. Pull-down assays identified EgeA-GFP binding to a transmembrane protein in the ER, Transport and Golgi organization protein 1 (TANGO1). By yeast two-hybrid analysis, EgeA-C directly bound Sec1 family domain-containing protein 1 (SCFD1), a host protein of the cis-Golgi network that binds TANGO1 at ER–Golgi exit sites (ERES). Both TANGO1 and SCFD1 localized to the Anaplasma inclusion surface. Furthermore, knockdown of Anaplasma EgeA or either host TANGO1 or SCFD1 significantly reduced Anaplasma infection. TANGO1 and SCFD1 prevent ER congestion and stress by facilitating transport of bulky or unfolded proteins at ERES. A bulky cargo collagen and the ER-resident chaperon BiP were transported into Anaplasma inclusions, and several ER stress marker genes were not up-regulated in Anaplasma- infected cells. Furthermore, EgeA transfection reduced collagen overexpression-induced BiP upregulation. These results suggest that by binding to the two ERES proteins, EgeA redirects the cargo-adapted ERES to pathogen-occupied inclusions and reduces ERES congestion, which facilitates Anaplasma nutrient acquisition and reduces ER stress for Anaplasma survival and proliferation.